Zoetis Inc. (ZTS) stock
ZTSNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 17/3046% below fair value
$83.48−0.91 (-1.08%)
Close on Nov 17, 2026Market cap $34.50BP/E 13.7Yield 2.43%
Zoetis total assets
Total assets on the balance sheet at the end of each period.
Zoetis's total assets was $15.08B at Jun 30, 2026. For fiscal 2025 it was $15.49B, up 8.8% from the year before. Over ten years it grew 6.9% a year on average. The highest annual figure on record is $15.49B in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $15.49B | +8.8% |
| FY2024 | Dec 31, 2024 | $14.24B | -0.3% |
| FY2023 | Dec 31, 2023 | $14.29B | -4.3% |
| FY2022 | Dec 31, 2022 | $14.93B | +7.4% |
| FY2021 | Dec 31, 2021 | $13.90B | +2.1% |
| FY2020 | Dec 31, 2020 | $13.61B | +17.9% |
| FY2019 | Dec 31, 2019 | $11.55B | +7.1% |
| FY2018 | Dec 31, 2018 | $10.78B | +25.5% |
| FY2017 | Dec 31, 2017 | $8.59B | +12.2% |
| FY2016 | Dec 31, 2016 | $7.65B | -3.3% |
| FY2015 | Dec 31, 2015 | $7.91B | +20.1% |
| FY2014 | Dec 31, 2014 | $6.59B | +0.5% |
| FY2013 | Dec 31, 2013 | $6.56B | +4.7% |
| FY2012 | Dec 31, 2012 | $6.26B | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $15.08B | +4.1% |
| Q1 FY2026 | Mar 31, 2026 | $15.15B | +7.5% |
| Q4 FY2025 | Dec 31, 2025 | $15.49B | +8.8% |
| Q3 FY2025 | Sep 30, 2025 | $15.16B | +5.6% |
| Q2 FY2025 | Jun 30, 2025 | $14.48B | +2.2% |
| Q1 FY2025 | Mar 31, 2025 | $14.10B | -1.7% |
| Q4 FY2024 | Dec 31, 2024 | $14.24B | -0.3% |
| Q3 FY2024 | Sep 30, 2024 | $14.36B | +1.8% |
| Q2 FY2024 | Jun 30, 2024 | $14.17B | +3.0% |
| Q1 FY2024 | Mar 31, 2024 | $14.35B | +4.3% |
| Q4 FY2023 | Dec 31, 2023 | $14.29B | -4.3% |
| Q3 FY2023 | Sep 30, 2023 | $14.11B | +3.2% |
| Q2 FY2023 | Jun 30, 2023 | $13.75B | -0.2% |
| Q1 FY2023 | Mar 31, 2023 | $13.75B | -0.8% |
| Q4 FY2022 | Dec 31, 2022 | $14.93B | +7.4% |
| Q3 FY2022 | Sep 30, 2022 | $13.67B | -0.2% |
| Q2 FY2022 | Jun 30, 2022 | $13.77B | -2.1% |
| Q1 FY2022 | Mar 31, 2022 | $13.86B | +0.5% |
| Q4 FY2021 | Dec 31, 2021 | $13.90B | +2.1% |
| Q3 FY2021 | Sep 30, 2021 | $13.71B | -0.1% |
| Q2 FY2021 | Jun 30, 2021 | $14.07B | +7.7% |
| Q1 FY2021 | Mar 31, 2021 | $13.80B | +19.7% |
| Q4 FY2020 | Dec 31, 2020 | $13.61B | +17.9% |
| Q3 FY2020 | Sep 30, 2020 | $13.73B | +21.8% |
| Q2 FY2020 | Jun 30, 2020 | $13.07B | +19.0% |
| Q1 FY2020 | Mar 31, 2020 | $11.53B | +5.9% |
| Q4 FY2019 | Dec 31, 2019 | $11.55B | +7.1% |
| Q3 FY2019 | Sep 30, 2019 | $11.27B | +7.8% |
| Q2 FY2019 | Jun 30, 2019 | $10.99B | +27.7% |
| Q1 FY2019 | Mar 31, 2019 | $10.88B | +25.2% |
| Q4 FY2018 | Dec 31, 2018 | $10.78B | +25.5% |
| Q3 FY2018 | Sep 30, 2018 | $10.46B | +12.6% |
| Q2 FY2018 | Jun 30, 2018 | $8.60B | +10.3% |
| Q1 FY2018 | Mar 31, 2018 | $8.69B | +13.6% |
| Q4 FY2017 | Dec 31, 2017 | $8.59B | +12.2% |
| Q3 FY2017 | Oct 1, 2017 | $9.29B | +20.4% |
| Q2 FY2017 | Jul 2, 2017 | $7.80B | – |
| Q1 FY2017 | Apr 2, 2017 | $7.65B | – |
| Q4 FY2016 | Dec 31, 2016 | $7.65B | – |
| Q3 FY2016 | Oct 2, 2016 | $7.72B | – |
See a number that looks wrong?